Management of Cyclosporine and Nifedipine-Induced Gingival Hyperplasia
- PMID: 26812935
- PMCID: PMC4717773
- DOI: 10.7860/JCDR/2015/14737.6974
Management of Cyclosporine and Nifedipine-Induced Gingival Hyperplasia
Abstract
Gingival enlargements modified by medications are becoming more common because of the increased use of inducing drugs, and may create speech, mastication, tooth eruption, periodontal, and aesthetic problems. We hereby present a case of a 54-year-old man with 12-month history of generalized gingival enlargement in the keratinized gingiva was referred to our clinic. The patient had a history of kidney transplant and was under medication of cyclosporine and nifedipine. After medical consultation, cyclosporine was changed to tacrolimus and nifedipine was changed to captopril. Gingivectomy was performed using a diode laser, and scaling and root planning were performed. At five months postoperative, the gingival enlargements relapsed and diode laser-assisted surgery was repeated. The patient was followed-up on second postoperatively at 18 months and no relapse was seen. Diode laser-assisted gingivectomy was found to be useful for coagulation during surgery and decreased postoperative bleeding. Recurrence risk of cyclosporine and nifedipine-induced gingival overgrowth is high, thus, there is a great need for prolonged care of patients following treatment and prosthetic restoration.
Keywords: Diode laser; Gingival overgrowth; Prosthetic restoration.
Figures
![[Table/Fig-1]:](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/782b/4717773/8f6e2d93fa8a/jcdr-9-ZD12-g001.gif)
![[Table/Fig-3]:](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/782b/4717773/7f841d788415/jcdr-9-ZD12-g002.gif)
![[Table/Fig-4]:](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/782b/4717773/4b31976e5560/jcdr-9-ZD12-g003.gif)
![[Table/Fig-5]:](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/782b/4717773/c6e6a1fa4812/jcdr-9-ZD12-g004.gif)
![[Table/Fig-6]:](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/782b/4717773/5e27f20027be/jcdr-9-ZD12-g005.gif)
![[Table/Fig-7]:](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/782b/4717773/a6ede2cbfc8c/jcdr-9-ZD12-g006.gif)
![[Table/Fig-8]:](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/782b/4717773/86ac96b207f9/jcdr-9-ZD12-g007.gif)
Similar articles
-
Periodontal Microbiological Status Influences the Occurrence of Cyclosporine-A and Tacrolimus-Induced Gingival Overgrowth.Antibiotics (Basel). 2019 Aug 21;8(3):124. doi: 10.3390/antibiotics8030124. Antibiotics (Basel). 2019. PMID: 31438651 Free PMC article.
-
Effect of treatment on cyclosporine- and nifedipine-induced gingival enlargement: clinical and histologic results.Int J Periodontics Restorative Dent. 1998 Feb;18(1):80-5. Int J Periodontics Restorative Dent. 1998. PMID: 9558559
-
Surgical treatment of cyclosporine A- and nifedipine-induced gingival enlargement: gingivectomy versus periodontal flap.J Periodontol. 1998 Jul;69(7):791-7. doi: 10.1902/jop.1998.69.7.791. J Periodontol. 1998. PMID: 9706857 Clinical Trial.
-
Prevention and treatment considerations in patients with drug-induced gingival enlargement.Curr Opin Periodontol. 1997;4:59-63. Curr Opin Periodontol. 1997. PMID: 9655022 Review.
-
[Clinical experience with the treatment of gingival hyperplasia induced by calcium channel blocking agents].Fogorv Sz. 1999 Dec;92(12):363-72. Fogorv Sz. 1999. PMID: 10641419 Review. Hungarian.
Cited by
-
Cyclosporine A and amlodipine induced gingival overgrowth in a kidney transplant recipient: case presentation with literature review.BMJ Case Rep. 2019 May 28;12(5):e229587. doi: 10.1136/bcr-2019-229587. BMJ Case Rep. 2019. PMID: 31142490 Free PMC article. Review.
-
Calcium Channel Blockers Induced Gingival Overgrowth: A Comprehensive Review from a Dental Perspective.J Int Soc Prev Community Dent. 2022 Jun 29;12(3):309-322. doi: 10.4103/jispcd.JISPCD_57_22. eCollection 2022 May-Jun. J Int Soc Prev Community Dent. 2022. PMID: 35966914 Free PMC article. Review.
-
Cyclosporine A-Induced Conchal Hyperplasia with Nasal Obstruction in a Patient with Membranous Nephropathy.Am J Case Rep. 2022 May 21;23:e935362. doi: 10.12659/AJCR.935362. Am J Case Rep. 2022. PMID: 35642551 Free PMC article.
References
-
- Miranda J, Brunet L, Roset P, Berini L, Farre M, Mendieta C. Prevalence and risk of gingival enlargement in patients treated with nifedipine. J Periodontol. 2001;72(5):605–11. - PubMed
-
- Hernandez G, Arriba L, Frias MC, et al. Conversion from cyclosporin A to tacrolimus as a non-surgical alternative to reduce gingival enlargement: a preliminary case series. J Periodontol. 2003;74(12):1816–23. - PubMed
-
- James JA, Boomer S, Maxwell AP, et al. Reduction in gingival overgrowth associated with conversion from cyclosporin A to tacrolimus. J Clin Periodontol. 2000;27(2):144–48. - PubMed
-
- Hernandez G, Arriba L, Lucas M, de Andres A. Reduction of severe gingival overgrowth in a kidney transplant patient by replacing cyclosporin A with tacrolimus. J Periodontol. 2000;71(10):1630–36. - PubMed
-
- Lam DK, Jan A, Sandor GK, Clokie CM. Prevention of infective endocarditis: revised guidelines from the American Heart Association and the implications for dentists. J Can Dent Assoc. 2008;74(5):449–53. - PubMed
Publication types
LinkOut - more resources
Full Text Sources